Medical Stocks To Consider: Galectin Therapeutics Inc.(NASDAQ:GALT), Dynavax Technologies Corporation(NASDAQ:DVAX), and Cannabis Science Inc.(OTCMKTS:CBIS)

Posted by admin August 28, 2014 0 Comment 538 views

New York, NY – 08/28/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

Galectin Therapeutics Inc.(NASDAQ:GALT) enjoyed a 22.71% boost in value as the stock gained $1.14 to move to a new closing price of $6.16. Nevertheless, the stock’s value is than a third of its 52 week trading high of $19.11. Galectin Therapeutics, Inc.(NASDAQ:GALT) is currently facing a lawsuit from shareholders regarding possible violations of Federal Securities Laws. As a result of the lawsuit, the stock’s trading volume has spiked to a figure of 1,938,222, which is significantly higher than its three month average of 691,589.

Is Galectin Therapeutics Worth A Short-Term Investment? View Our Free GALT Analysis.

Dynavax Technologies Corporation(NASDAQ:DVAX) fell three cents to finish the day at a closing price of $1.42. The California-based clinical-stage biopharmaceutical company has not published a press release since the company reported its second quarter financial results on Aug. 7th. Nevertheless, Dynavax Technologies Corporation(NASDAQ:DVAX) remains a relatively active stock with its trading volume just slightly below its three month average. The stock, which has traded within a range of $1.10 to $2.14 over the past 52 weeks, regained one cent during after-hours trading.

What Is It About Dynavax Technologies That Is Attracting Stockholders? Receive A Free DVAX Analysis.

Cannabis Science Inc(OTCMKTS:CBIS) suffered a 2.11% loss in value as the stock lost $0.0016 to fall to a closing price of $0.0744. The Colorado-based phytocannabinoid-based pharmaceutical products developer has closed within a range of $0.0720 to $0.1260 over the past three months. On Aug. 26th, Cannabis Science Inc(OTCMKTS:CBIS) provided updated guidance for its canabis cultivation programs in Europe and North America. The company also recently announced it was in final negotiations to acquire a company from British Columbia.

What Does Cannabis Science’s Colorado Expansion Mean For The Company’s Future? Click Here For A Free CBIS Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment